MEDTOX Scientific (MTOX) Posts Q2 EPS of $0.11, Short of Views
MEDTOX Scientific, Inc. (Nasdaq: MTOX) reports Q2 EPS of $0.11, versus the analyst estimate of $0.13. Revenue for the quarter was $25.2 million, which compares to the estimate of $23.63 million.
You May Also Be Interested In
- H&R Block (HRB) Announces New Capital Structure, Approves $3.5B Common Stock Buyback
- Exa (EXA) Tops Q2 EPS by 2c
- Bob Evans Farms (BOBE) Tops Q1 EPS Views; Boosts FY16 EPS Outlook
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!